Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ACS Medicinal Chemistry Letters is Scopus-indexed (Q2, CiteScore 5.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by American Chemical Society.
Checked against the index lists dated .
ISSN 1948-5875Verify ISSN ↗
Publisher: American Chemical Society
Cost to publish: About US$4,500 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Organic Chemistry | 79 / 215 | 63rd | Q2 |
| Drug Discovery | 68 / 161 | 58th | Q2 |
| Biochemistry | 197 / 448 | 56th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q2, CiteScore 5.6.
ACS Medicinal Chemistry Letters is Q2 in Organic Chemistry (rank 79 of 215), Q2 in Drug Discovery (rank 68 of 161) and Q2 in Biochemistry (rank 197 of 448), by CiteScore 2025.
ACS Medicinal Chemistry Letters is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.6, which places it in quartile Q2 at the 63rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.697, quartile Q1, with an H-index of 101.
The publisher lists an article processing charge of about US$4,500 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
ACS Medicinal Chemistry Letters is published by American Chemical Society. Its ISSN is 1948-5875.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
ACS Medicinal Chemistry Letters has an h-index of 110 and a 2-year mean of 2.18 citations per paper (OpenAlex). Its Scopus CiteScore is 5.6, quartile Q2. On 2-year citations it ranks #118 of 210 Scopus journals in Organic Chemistry.
ACS Medicinal Chemistry Letters published 522 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 86 research articles (2026), authors are most often from United States (43.3%), India (10.4%) and China (7.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.